Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Single Step, Direct ELISA Measures Free Testosterone

By LabMedica International staff writers
Posted on 18 Sep 2012
A single-step direct ELISA measurement of free testosterone saves laboratories time and money while reducing the possibility of errors.

The ability to directly measure free testosterone eliminates the complication of taking multiple indirect measurements and calculating free testosterone through an algorithm. More...
Diagnostic technologies have inherent limitations in terms of both precision and accuracy. Combining multiple procedures worsens these limitations and increases both the cost and opportunity for errors.

The ThunderBolt delivers power and flexibility in a small size. The dual function analyzer provides complete, walk-away automation of 192 patient samples in only a 61 cm by 61 cm space. Completely open architecture allows any enzyme immunoassay (EIA) or clinical laboratory improvement amendments (CLIA) protocol to be programmed. Up to eight different protocols can run in a single batch. Intuitive and robust software further enriches the ThunderBolt, making it the total laboratory automation solution. The ThunderBolt delivers power and flexibility in a small size.

The combination of free and total testosterone gives healthcare professionals more information to make the correct diagnosis when a testosterone-related condition is suspected. Gold Standard Diagnostics (GSD; Davis, CA, USA) also offers an ELISA test for total testosterone level to complement the free testosterone assay.

Total testosterone measures levels of all forms in the blood stream, including: unbound (free), loosely bound to albumin and tightly bound to sex-hormone binding globulin (SHBG). Many common factors influence SHBG levels. As a result, a total testosterone assessment may yield a normal result, but due to higher or lower levels of testosterone-SHBG bonding, the concentration of free testosterone may not correlate directly with total testosterone readings.

SHBG levels can be increased by factors such as obesity and testosterone treatment. Factors that can decrease SHBG levels include aging, pregnancy, and estrogen therapy. Symptoms of low testosterone in males include decreased sexual function, erectile dysfunction, loss of hair, decreased muscle mass, and osteoporosis. For females, symptoms include hot flashes, irritability, decreased libido, and insomnia.

Gold Standard Diagnostics (GSD) provides comprehensive diagnostic solutions that improve lab efficiency and minimize overall costs. Through an extensive product menu, automated instrument platforms, and good customer service, GSD solves laboratory problems.

Related Links:

Gold Standard Diagnostics



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.